Literature DB >> 8219865

Caring for patients with HIV infection. Management plan for family physicians.

G Bally1.   

Abstract

Caring for and treating patients living with human immunodeficiency virus is challenging for busy family physicians. I present one strategy for managing patients with this complex infectious disease. Using averaged T4 blood cell counts as a marker of disease progression, I use antiretroviral treatment and preventive drug therapy against the complications of HIV infection.

Entities:  

Mesh：

Year:  1993        PMID： 8219865      PMCID： PMC2379870     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  15 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis.

Authors:  T J Jordan; E M Lewit; R L Montgomery; L B Reichman
Journal:  JAMA       Date:  1991-06-12       Impact factor: 56.272

Review 3.  Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.

Authors:  J J Ellner; M J Goldberger; D M Parenti
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

4.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.

Authors:  N M Graham; K E Nelson; L Solomon; M Bonds; R T Rizzo; J Scavotto; J Astemborski; D Vlahov
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

5.  Cytomegalovirus infection in patients with AIDS.

Authors:  W L Drew
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

6.  Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.

Authors:  J P Aboulker; A M Swart
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

Review 7.  The natural history of human immunodeficiency virus infection.

Authors:  A R Lifson; G W Rutherford; H W Jaffe
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.

Authors:  T C Meng; M A Fischl; A M Boota; S A Spector; D Bennett; Y Bassiakos; S H Lai; B Wright; D D Richman
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

9.  CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use.

Authors:  J M Taylor; J L Fahey; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

10.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.